In 1985 I was a young physician in internal medicine training. In that year, pharmaceutical companies were allowed to advertise not only to physicians as had been true in the past, but were now free to promote their medications to the general public. At the time, I wondered why Pharma would want to spend more money less efficiently. Over the years, as I have observed little evidence in support of direct-to-patient marketing, the question remained. Recent events, however, have opened my eyes. At the end of January, Project Veritas released a video featuring a senior executive physician at Pfizer caught...